Avecia Biotechnology, which focuses mainly on the development and manufacturing of oligonuceotide medicines, has been acquired by Japanese firm Nitto …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

